Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 32,770 shares at $165.89 ($5.4M) on 2021-11-12, disclosed to the SEC on 2021-11-16.
Open-market sale of $5.4M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $163.10 | 1,030 | $168K | 3.1% |
| 2 | $164.18 | 4,122 | $677K | 12.5% |
| 3 | $164.18 | 4,122 | $677K | 12.5% |
| 4 | $164.87 | 6,872 | $1.1M | 21.0% |
| 5 | $164.87 | 6,872 | $1.1M | 21.0% |
| 6 | $165.89 | 4,776 |
| $792K |
| 14.7% |
| 7 | $165.89 | 4,776 | $792K | 14.7% |
| 8 | $167.27 | 100 | $17K | 0.3% |
| 9 | $168.34 | 100 | $17K | 0.3% |
| Total | $164.96 avg | 32,770 | $5.4M | 100% |
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |